Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
26.54Price to Free Cash Flow
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 30.41M | $ 806.96M | 26.54 |
| 3/31/2025 | $ -13.63M | $ 756.92M | 0 |
| 12/31/2024 | $ -50.73M | $ 478.43M | 0 |
| 9/30/2024 | $ -56.15M | $ 609.81M | 0 |
| 6/30/2024 | $ -51.2M | $ 274.83M | 0 |
| 3/31/2024 | $ -45.7M | $ 297.33M | 0 |
| 12/31/2023 | $ -38.74M | $ 188.04M | 0 |
| 9/30/2023 | $ -33.98M | $ 171.56M | 0 |
| 6/30/2023 | $ -31.34M | $ 242.24M | 0 |
| 3/31/2023 | $ -28.24M | $ 233.7M | 0 |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, CORMEDIX INC's average P/FCF has been 26.54.
- The median P/FCF for CORMEDIX INC during this period was 26.54
- CORMEDIX INC reached its highest P/FCF over the past 5 years at 26.54.
- The lowest P/FCF recorded by CORMEDIX INC in the same timeframe 26.54
CORMEDIX INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for CORMEDIX INC is calculated as follows: Market Cap [ $ 172.87M ] / FCF [ $ -19.96M ]
(=) P/FCF [ 0 ] CRMD - Price to Free Cash Flow, Last 5 years
26.54
Minimum
Jun 30, 2025
26.54
Maximum
Jun 30, 2025
26.54
Average
26.54
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.32 with a standard deviation of 12.94.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.32 |
| median | 14.76 |
| std | 12.94 |